Source: PR Newswire

Press Release: Keranetics : KeraNetics announces KeraStat Cream product cleared by FDA for radiation dermatitis

WINSTON-SALEM, N.C., July 20, 2020 /PRNewswire/ -- KeraNetics Inc. announces today that the next product in its KeraStat® wound dressing portfolio, KeraStat® Cream, has been cleared by the US Food and Drug Administration for indications of radiation dermatitis. This product is designed to...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kim D. Westmoreland's photo - CEO of Keranetics

CEO

Kim D. Westmoreland

CEO Approval Rating

70/100

Read more